This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Algipharma as, University College Cardiff Consultants Limited. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014-2017
Introduction
Timothy Rutland Walsh, based in Cardiff, GB, is an influential inventor with a notable focus on advancing healthcare solutions. With a total of four patents to his name, Walsh's work primarily addresses the pressing challenge of antibiotic resistance in bacteria, an increasing concern in medical and environmental contexts.
Latest Patents
One of Walsh's most significant contributions is encapsulated in his latest patent for "Alginate oligomers for use in overcoming multidrug resistance in bacteria." This innovative invention offers a method to combat antibiotic resistance in multidrug-resistant bacteria by utilizing alginate oligomers in conjunction with antibiotics. The method is applicable to bacteria found on both animate and inanimate surfaces, paving the way for both medical and non-medical applications, including disinfection and cleaning protocols.
Career Highlights
Walsh has collaborated with prominent companies including Algipharma AS and University College Cardiff Consultants Limited. His career reflects a dedicated pursuit of innovative solutions aimed at tackling critical challenges in bacterial resistance.
Collaborations
Throughout his career, Timothy has worked alongside talented individuals such as David Thomas and Edvar Onsoyen. These collaborations have further enriched his contributions to the field and propelled collective efforts toward significant breakthroughs in combating multidrug-resistant bacteria.
Conclusion
Timothy Rutland Walsh stands out in the realm of inventors, particularly due to his impactful methodologies in addressing antibiotic resistance. His research and patents signify a commitment to improving health outcomes and environmental safety, making him a noteworthy figure in contemporary innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile